So you know this for a fact do you? Where is the link to this fact or are you talking BS again? The $20M CN at 125% of 3.8c make a lot of sense as this is dependent on the clinical trial updates for VAXINIA and OASIS expected in the next 2-5 months and the $26M are exercisable at 5c. If IMU was so "desperate" as there brokers declined their offer then the CN and warrant wouldn't have been at a premium, this is evident by the recent quarterly showing they didn't need to do a CR right now and by what LC said but PH got a good deal so pull the trigger early. A traditional CR by brokers would have been at 25% discount and immediately dump into the market for 10-20% gain so logically using my brain, you are talking BS and got called out AGAIN.
The Cholangiocarcinoma and DLBCL market might be small in patient but treatment cost for rare disease are expensive and that's why the current treatment cost for both of them is expensive. Anyway, the most important clinical trial update will be OASIS as LC has been saying the investors in the US are interest in this IP so you got called out AGAIN.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)